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Abstract We aimed to estimate clinicians’ based risk thresholds
at which febrile children would be managed as serious bacterial
infections (SBI) to determine influencing characteristics and to
compare thresholds with prediction model (Feverkidstool) risk
estimates. Twenty-one video vignettes of febrile children visiting
the emergency department (ED) were assessed by 42 (40.4 %)
international paediatricians/paediatric emergency clinicians.
Questions were related to clinical risk scores of the child having
SBI and SBI management decisions on visual analogue scales.
Feverkidstool risk scores were based on clinical signs/symptoms
and C-reactive protein. Amongst vignettes assigned to SBI man-
agement, the median risk was 60 % (interquartile range (IQR)
30.0–80.5) and 16.0 % (IQR 5.0–32.0) when vignettes were not
managed as SBI. Ill appearance and aberrant circulatory signs
were the most influencing factors, as age and duration of fever
were the least influencing factors on SBI management decisions.
Feverkidstool risk scores varied from 13 % (IQR 7.7–28.1) for
SBI management to 7.3 % (IQR 5.7–16.3) for no SBI
management.
Conclusion: Clinicians assigned high risk scores to children
who they would have managed as SBI, mostly influenced by ill
appearance and aberrant circulation. In contrast to SBI risk as-
sessment of the Feverkidstool, clinicians’ appeared to apply a
more stepwise assessment of the risk of presence/absence of
SBI at different steps in the diagnostic and therapeutic process.
Uniform risk thresholds at which one should start SBI manage-
ment in febrile children remains unclear; risk thresholds at which
we refrained from SBI management were more consistent.
What is Known:
• Only a small proportion of febrile children presenting to the emergency
department will have serious bacterial infections (SBI) and uniform risk
thresholds to start or withhold SBI treatment are not known.
• The low prevalence of SBI and consequently the low exposure of
clinicians to these infections make them rely more on alarming signs or
clinical decision rules.
What is New:
• Previously identified model predictors for SBI appeared to be
significantly influencing factors in clinicians’ febrile child management
in emergency care.
• Clinicians’ wielded higher risk thresholds regarding SBI febrile child
management than reflected by the clinical prediction model.
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Introduction
The febrile child is a common presentation to emergency de-
partments (ED) with 10 to 20 % of all paediatric patients due
to febrile illness alone [14, 17, 28]. Most children suffering
from simple self-limiting infections do not need treatment.
However, a small proportion will have serious bacterial infec-
tions (SBI) which require investigation, hospital admission,
antibiotics and in some cases intensive care admission.
Understanding health care professionals’ decision making,
particularly regarding to diagnosis, treatment and follow-up is
of vital importance, particularly as ED’s become increasingly
overcrowded [33, 34]. Moreover, diagnostic errors, especially
in infectious diseases, are amongst the most common medical
misadventures of malpractice lawsuits in paediatrics [16].
To support decision making in febrile children, different
clinical prediction models have been developed in the past
decade [4, 7, 12, 19, 30, 31]. Although most studies on pre-
diction models report good accuracy and high compliance,
implementation in paediatric emergency care is limited. One
of the reasons might be that clinicians’ intuitive estimation of
probabilities may be as good as, or better than, prediction
models [15, 21, 27]. Moreover, the lack of evidence on clin-
ically based decision thresholds makes the application process
of prediction models in clinical practice complex.
The aim of this study was to estimate risk thresholds at
which children would be managed as SBI according to clini-
cians’ judgement by assessment of video vignettes of febrile
children visiting the ED. Secondary measures included deter-
mining the effect of investigations by recording risk estima-
tions after information on C-reactive protein value, determin-
ing the presenting characteristics that influence these risks and
comparing clinician perceived risk with risk estimates using a
validated prediction model (Feverkidstool) [19].
Methods
Study design and setting
We performed a cross-sectional study with real life video vi-
gnettes of febrile children who presented themselves to the
children’s ED of the Leicester Royal Infirmary in Leicester,
UK. All parents had given formal consent for the video images
to be viewed by healthcare professionals under trust policy
guidelines via previously published process [13]. Ethical consent
for the collection of video images process had been granted by
the National Research Ethics Committee East Midlands.
Study population
Paediatricians and paediatric emergency clinicians from the
source population of the REPEM network (Research in Pae-
diatric Emergency Medicine, Europe; www.pemdatabase.org/
REPEM.html), and Paediatricians at teaching hospitals with
an interest in acute and emergency care in the Netherlands and
United Kingdom, were invited (104 invitations). Non-
responders were sent reminders at 4-week intervals, for a max-
imum of four mailings per subject.
Study intervention—video vignettes
Twenty-one online video vignettes of febrile children were
shown to the study participants. The vignettes were a mix of
children in different age categories with potential SBI and
children with simple self-limiting problems reflecting the dif-
ferent levels of severity in febrile child presentations in prac-
tice. The videos, with a mean duration of about 30 s, were
originally recorded for educational purposes of paediatricians
in training as part of the REMIT (Refining Evaluation Meth-
odologies for Practice Changing Interventions) study
(ISRCTN94772165). Background history and vital signs were
reported as added text or could easily be interpreted from the
video vignettes.
Initially, the participants were asked if they should manage
the febrile child as having a SBI based on the vignette and
background history (e.g. duration of fever) alone. Next, they
were asked to assess the actual risk of the child having a SBI
on a visual analogue scale (VAS1). Finally, we add different
values of C-reactive protein (CRP) and asked if their risk
assessment would have changed (VAS2). The online vignettes
and the respondents were hosted on a secure password
protected server.
Data collection
All data collected online was exported in an anonymised for-
mat as an Excel file. We collected answers on the following
questions: (1) Would you manage this child as having a seri-
ous bacterial infection? (Answers: yes/no). (2) Which diag-
nostics or therapeutics would you perform? (Options: no ac-
tion and/or discharge; antipyretic; fluid trial; blood tests;
chest-radiography; lumbar puncture; urine dipstick; oral anti-
biotics; intravenous antibiotics; admission). Study participants
could tick as many items as they judged relevant. (3) What is
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the chance of SBI in this child? (Answer: 0–100 % on a VAS
(VAS1)) [1]. As CRP is the strongest predictor of the
Feverkidstool, we studied the additional value of CRP in cli-
nicians’ management decision, with the following question:
(4) A CRP is taken and returns at (continuous value) mg/l.
What is the chance of SBI in this child? (Answer: 0–100 %
VAS (VAS2)).
Participant’s background information was collected after
finishing the video vignettes. These questions included (1)
Are you a: Emergency Medicine clinician/Paediatrician; (2)
How long have you been working as an Emergency Medicine
clinician/paediatrician? (Options: <5 years; 5–10 years; 10–
15 years; >15 years); (3) Have you ever missed/recognised a
serious infection too late? (Options: yes/no).
Definitions and outcome measures
All participants were informed about the predefined SBI def-
inition in the letter for the study invitation: culture or radio-
graphically proven bacterial infection (e.g. meningitis, sepsis,
bacteremia, pneumonia, urinary tract infection, bacterial gas-
troenteritis, osteomyelitis or ethmoiditis). The outcome SBI in
the vignettes was defined as management of the child as hav-
ing a SBI.
Detailed descriptions on the Feverkidstool development
and validation have been published earlier [19]. The originally
reported discriminative ability according to the area under the
receiver operating characteristic curve (AUC) of the model to
predict pneumonia was 0.81 (standard error 0.04) and for oth-
er SBI 0.86 (standard error: 0.03) [19]. As the Feverkidstool
was based on a polytomous logistic regressionmodel, two risk
scores were calculated, one for pneumonia and one for other
SBI (e.g. urinary tract infection). We used the highest risk
score in the comparison with the VAS risk scores of the video
vignettes. We dichotomised the outcome of performed diag-
nostics and/or therapeutics. This outcome was scored ‘pres-
ent’ if participants ticked fluid trial, blood tests, chest-radiog-
raphy, lumbar puncture, urine dipstick, administration of oral/
intravenous antibiotics and/or admission. When ‘no action
and/or discharge and/or antipyretics’was chosen, the outcome
was scored as ‘not present’.
All vignettes had a statement on age, temperature and du-
ration of fever. Abnormal clinical signs and symptoms were
distributed amongst the different vignettes, with ten vignettes
having one alarming sign, four vignettes with two alarming
signs and seven vignettes having three ormore alarming signs.
Statistical analysis
First, we assessed the range of estimated median risks by
clinical judgement (VAS) and the risk with the added value
of CRP. Second, we measured the patient characteristics
which enact SBI management with discrete choice experiment
(DCE) analysis. Finally, we compared VAS risk scores with
prediction model based judgement (Feverkidstool).
DCEs are a quantitative approach to assess preferences
for e.g. medical interventions and are increasingly used in
health care [10]. In DCEs, it is assumed that important
items influencing medical interventions, such as vital
signs, can be described by its characteristics (i.e. attri-
butes) [24]. Those characteristics are further specified by
variants of that characteristics (i.e. attribute levels). A
second assumption is that the levels of those attributes
are determined by the individuals’ preference for a medi-
cal intervention [24]. We studied the clinical variables of
the Feverkidstool (www.erasmusmc.nl/feverkidstool) as
attributes to the decision whether or not to manage
febrile children of the vignettes as a SBI [13]. All DCE
data was analysed by taking each choice amongst the two
management alternatives as an observation. Using the
Nlogit software http://www.limdep.com/ to the next
sentence, the observations were analysed by a logit
model. As there was a lack of diversity amongst the
clinical variables ‘oxygen saturation’ and ‘tachypnoea’
between the vignettes, we could not analyse these
variables accordingly. The variables tachycardia and
prolonged capillary refill were taken together as one
clinical variable as their correlation was too high. The
influence of the different variable coefficients was tested
for statistical significance (p value ≤0.05). As at this
moment, no formal statistical methods to determine
sample sizes for DCE exist; our study strived to reach at
least 40 respondents in line with previous studies [6, 26].
Results
Of the 104 invited participants, 50.4 % agreed to participate
and 42 (40.4 %) participants finished the online video vi-
gnettes. The 42 final participants included 83% paediatricians
and 17% paediatric emergency medicine physicians. Fifty per
cent of the participants had a working experience of more than
10 years. Almost half of the participants had at least once
missed or delayed recognised serious infection (Table 1).
Study intervention—video vignettes
In Table 2, clinical characteristics of the video vignettes are
summarised. Median age of the children was 12.0 months
(interquartile range (IQR) 2.0–72.0), 57 % were boys and
the median C-reactive protein level (CRP) was 60 mg/l (IQR
10.0–110.0). Answers on the four questions of the video vi-
gnettes are summarised in Table 3. Forty-one per cent of the
video vignettes are managed as having a SBI according to the
participants. Diagnostics and/or therapeutics were started in
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77 % of the video vignettes. Median risk before the knowl-
edge of CRP (VAS1) was 20.0 % (IQR 9.0–50.0) and with
CRP information the risk (VAS2) increased to 30.0 % (IQR
10.0–60.0). As CRP values were already available in the first
video for vignette 3 and 21, no change in risk could be mea-
sured. Details of performed diagnostics, therapeutics and
follow-up are described in Table 4. More diagnostics and/or
therapeutics were performed when the child was managed as
SBI. Antipyretics were given in 65 % of the video vignettes
with no differences when stratifying by outcome (SBIM).
In 94 % of the video vignettes who were managed as
SBI, blood tests were done and 71 % were hospitalised
(Table 4).
Clinical judgement versus different levels of CRP
In Fig. 1, the differences in clinical risk scores are visualised
versus different levels of CRP values. The median clinical risk
differences (VAS2-VAS1) were positively correlated with a
higher level of CRP (SBIM yes: Pearson correlation 0.53
(p=0.000) and SBIM no: Pearson correlation 0.68 (p=
0.000)). Risk scores of children classified initially already as
being managed as SBI were influenced only by high
levels of CRP (>65 mg/l), whereas children not man-
aged initially as SBI were influenced by lower CRP
levels (>40 mg/l) (Fig. 1).
Discrete choice experiment—video vignettes
Discrete choice experiment was based upon 20 video vi-
gnettes as the clinical variables of one video were too corre-
lated. Almost all clinical variables of the Feverkidstool could
be tested with DCE analysis, except for CRP, oxygen satura-
tion and tachypnoea. Ranking and coefficients of influencing
variables on management decision of febrile children accord-
ing to the DCE analysis are presented in Table 5. All tested
clinical variables influenced the decision on management of
febrile children significantly. Ill appearance and the combined
variables of prolonged capillary refill and tachycardia were the
most influencing factors and age and duration of fever the
least influencing factors.
Risk scores video vignettes—risk scores Feverkidstool
The median clinical risk score (VAS2) according to the partic-
ipants amongst those video vignettes who were assigned as
managed as SBI was 60.0 % (IQR 30.0–80.5) compared to a
risk score according to the Feverkidstool of 12.7 % (IQR 7.7–
28.1) (Table 6). When the video vignettes were not managed
as SBI, the clinical risk score (VAS2) amounted to 16.0 %
(5.0–32.0) compared to a risk of 7.3 % (5.7–16.3) according
the Feverkidstool (Table 7). The largest risk score differences
between the vignettes and risk scores according to the
Feverkidstool were seen for video vignettes with (various
levels of) decreased consciousness or agitation. This item is
Table 2 Clinical variables
Video vignettes (n=21)
Clinical variables
Age (months)a 12.0 (2.0–72.0)
≤3 months 4 (19.0)
>3 months–<1 year 6 (28.6)
≥1 year–≤18 months 5 (23.8)
>18 months 6 (28.6)
Sex, male* 12 (57.1)
Temperaturea(°C) 38.7 (38.5–40.2)
38.5–38.9 °C 12 (57.1)
39.0–39.9 °C 7 (33.3)
≥40.0 °C 2 (9.5)
Duration fevera (days) 2.0 (1.0–3.0)
Prolonged capillair refill* (>2 s) 4 (19.0)
Chest wall retractions* 3 (14.3)
Ill appearance* 7 (33.3)
Saturation (<94 % O2)
* 1 (4.8)
Respiratory ratea (/minute) 32.0 (20.0–60.0)
Tachypnoea 1 (4.8)
Heart ratea (/minute) 132.0 (100.0–172.0)
Tachycardia 4 (19.0)
CRPa (mg/L) 60.0 (10.0–110.0)
<40 mg/l 8 (38.1)
≥40 mg/l 7 (33.3)
≥80 mg/l 6 (28.6)
Presence of no. alarming symptomsa
≤1 11 (0–1)
>1 10 (2–5)
*Absolute number (percentage)
aMedian (min; max)
Table 1 Demographics
Participants (n=42)
Specialisma
Paediatric emergency medicine clinician 7 (16.7)
Paediatrician 35 (83.3)
Years of working experiencea
<5 years 4 (9.5)
5–10 year 17 (40.5)
10–15 years 9 (21.4)
>15 years 12 (28.6)
Missed/recognised a serious infection too latea
Yes 19 (45.2)
No 23 (54.8)
a Absolute number (percentage)
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clearly observed when watching the video vignettes, but this
clinical variable is not included in the predictors of the
Feverkidstool. Finally, no differences were found in median
clinical risk scores when stratified for previously missed diag-
noses of the participant (p=0.218).
Discussion
Main findings
This is the first study on real life video vignettes to determine
febrile child characteristics which enact clinicians’
management decisions. High clinical risk scores to manage
febrile children as SBI were created by clinicians. All tested
clinical variables of the Feverkidstool influenced clinicians’
management decisions of febrile children significantly with ill
appearance and aberrant circulatory signs being the most im-
portant. Moderate CRP levels influenced risk scores in chil-
dren who were initially not managed as SBI whereas high
CRP levels were needed to influence risk scores in children
who were initially already managed as SBI. In children man-
aged as SBI risk thresholds judged by the clinician were
higher compared with predicted risk thresholds according to
the Feverkidstool. Clinical risk thresholds of children not
managed as having a SBI were more comparable to prediction
model-based risk thresholds.
Table 3 Answers of 42 participants on 21 video vignettes (ntotal=882)
Alarming symptoms Question 1 Question 2 Question 3 Question 4
Video vignette No. SBIM Dx/Tx* VAS1a (%) CRPa (mg/l) VAS2a (%)
1 2 3 (7.1) 16 (38.1) 10.0 (4.8–20.0) 85 26.5 (10.0–44.8)
2 1 29 (69.0) 42 (100.0) 30.0 (20.0–50.3) 70 54.5 (30.0–79.3)
3 1 11 (26.2) 26 (61.9) 16.0 (7.8–32.8) 38 10.0 (4.8–23.0)
4 3 27 (64.3) 39 (92.9) 27.0 (10.0–51.8) 100 60.0 (30.8–76.0)
5 3 41 (97.6) 42 (100.0) 81.0 (60.0–90.0) 65 71.5 (50.0–90.0)
6 3 13 (31.0) 36 (85.7) 20.5 (10.0–40.0) 90 44.0 (20.0–69.3)
7 1 23 (54.8) 33 (78.6) – 10 30.5 (11.0–60.3)
8 1 27 (64.3) 41 (97.6) 30.0 (14.0–50.0) 25 17.0 (10.0–29.3)
9 1 4 (9.5) 25 (59.5) 10.0 (4.0 21.0) 30 9.5 (4.0–21.0)
10 2 41 (97.6) 42 (100.0) 80.0 (62.5–90.0) 50 69.5 (40.0–90.0)
11 4 9 (21.4) 38 (90.5) 10.5 (5.0–21.0) 90 40.5 (21.0–69.0)
12 1 5 (11.9) 32 (76.2) 10.5 (5.8–21.0) 28 6.0 (4.0–14.5)
13 1 0 (0) 11 (26.2) 5.0 (2.8–15.5) 36 4.0 (0.8–12.0)
14 6 16 (38.1) 38 (90.5) 16.0 (9.8–40.0) 60 30.0 (16.3–50.0)
15 3 32 (76.2) 42 (100.0) 41.5 (20.0–69.3) 75 62.5 (38.5–80.0)
16 1 1 (2.4) 15 (35.7) 8.5 (2.8–15.8) 10 1.0 (0.0–6.0)
17 3 41 (97.6) 42 (100.0) 82.5 (69.8–93. 3) 48 81.5 (49.8–91.8)
18 2 7 (16.7) 32 (76.2) 11.5 (7.8–25.3) 110 60.0 (31.0–80.0)
19 1 9 (21.4) 24 (57.1) 15.5 (8.3–30.0) 75 30.5 (19.3–50.0)
20 1 16 (38.1) 35 (83.3) 21.0 (10.0–45.5) 35 13.5 (8.0–36.3)
21 2 10 (23.8) 29 (69.0) – 100 19.5 (6.8–30.3)
Total 365/882 (41.4) 680/882 (77.1) 20.0 (9.0–50.0) 60.0 (35.0–85.0) 30.0 (10.0–61.0)
*Absolute number (percentage); aMedian (25–75 percentile)
Question 1: Would you manage this child as having a serious bacterial infection?
SBIM : child is managed as having SBI according to participant
Question 2: Which diagnostics or therapy would you perform?
Dx/Tx: diagnostics and/ or therapy done (defined as: fluid trial; blood tests; chest-radiography; lumbar puncture; urine dipstick; administration of oral/
intravenous antibiotics or admission)
Question 3: What is the chance of SBI in this child? (Answer: 0–100 % on a VAS (VAS1 ))
VAS1 : risk assessment without knowledge of CRP (0–100 % VAS)
Question 4: A CRP is taken and returns at (continuous value) mg/l. What is the chance of SBI in this child? (Answer: 0–100 % VAS (VAS2 )
VAS2 : risk assessment with knowledge of CRP (0–100 % VAS)
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Comparison with literature
In this study, we aimed to get insight in patient characteristics
and contextual factors influencing management decisions of
the febrile child at the ED. One way to approach this process
of diagnostic reasoning is decision making [11]. Decision
making has been influenced by statistical models of reasoning
under uncertainty using pre- and post-test probability accord-
ing to Bayes’ theorem. This model deals with two major clas-
ses of errors in clinical reasoning: in the assessment of either
pretest probability or the strength of the evidence [11]. Al-
though the pretest probability of having SBI (prevalence
of disease) is depending on several factors as for exam-
ple age and relevant medical history, the pretest proba-
bility determined by health care setting was considered
stable in the vignettes. However, we focused on the
interpretation of clinicians’ strengths of evidence of the
probability of a serious infection. For this decision pro-
cess, we performed discrete choice experiment (DCE)
analysis, which is an increasingly used method applied
Table 4 Diagnostics, therapy and follow-up
Diagnostics SBIM yes n=365 SBIM no n=517 Ntotal=882
No diagnostics 4 (1.1) 100 (19.3) 104 (11.8)
Urine dipstick 252 (69.0) 134 (25.9) 386 (43.8)
Fluid trial 135 (37.0) 73 (14.1) 208 (23.6)
Blood tests 344 (94.2) 180 (34.8) 524 (59.4)
Chest-radiography 112 (30.7) 76 (14.7) 188 (21.3)
Lumbar puncture 140 (38.4) 9 (1.7) 149 (16.9)
Therapy and follow-up SBIM yes n=365 SBIM no n=517 Ntotal=882
Antipyretics 244 (66.8) 330 (63.8) 574 (65.1)
No therapy 74 (20.3) 404 (78.1) 478 (54.2)
Oral antibiotics 11 (3.0) 16 (3.1) 27 (3.1)
Intravenous antibiotics 209 (57.3) 4 (0.8) 213 (24.1)
Admission 258 (70.7) 96 (18.6) 354 (40.1)
Discharge 75 (20.5) 405 (78.3) 480 (54.4)
Fig. 1 Relation video vignettes
risk difference and C-reactive
protein (mg/l)
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in studies where clinicians weigh clinical information in
the diagnostic work-up [3].
In literature on diagnostic reasoning, evidence-based med-
icine is the most successful educational method in the
translation of statistical decision theory into clinical practice
[25]. Within this translation, we aimed to elaborate on the
determination of quantitative decision thresholds that proved
to be a complex topic. Most studies used optimised perfor-
mance measures as area under the receiver operating charac-
teristic curve (AUC) or sensitivity/specificity to establish
these thresholds. Other studies described Delphi procedures
to determine their clinical based cutoff points [5, 18, 20, 22,
32]. In our study, we described clinicians’ assigned median
risk estimates according to which patients would have been
managed as SBI. We observed agreement on clinical and pre-
diction model-based risk thresholds when clinicians decided
not to manage the febrile child as a SBI. However, the clinical
risk threshold to manage the child as SBI was much higher
compared with prediction model-based judgement. This phe-
nomenon is well recognised, as clinicians don’t want to miss
serious, but treatable diseases, there is a tendency to overesti-
mate the probability of these diseases [11].
Clinical and research implications
The most important finding of this study includes the high risk
scores clinicians assigned to those children who they would
have managed as SBI (median risk 60.0 % (IQR 30–80.5)).
This observation is in contrast to our hypothesis that very low
risk thresholds might be chosen for specific diagnosis with
high morbidity/mortality (e.g. meningitis). Apparently, clini-
cians create more dichotomous risk estimations (high risk or
low risk) for the management of specific serious infections
with reassessment of risk estimates after every diagnostic step.
Clinicians used a stepwise approach in the management of
febrile children, rather than considering one risk thresholds
for SBI in general. We observed agreement in predictive value
of all tested clinical predictor variables in the detection of
children with SBI, for both clinical-based as prediction
model-based judgement. Clinicians were guided by ill
Table 5 Influencing variables on
management decisions in febrile
children (SBIM): a discrete choice
experiment (ntotal=882)
Clinical variables Ranking Coefficients (SE) p value
Intercept −0.92 (0.37) 0.013
Ill appearance 1 1.15 (0.13) <0.001
Prolonged capillary refill (>2 s) and/or tachycardia 2 0.99 (0.17) <0.001
Chest wall retractions 3 −0.97 (0.22) <0.001
Temperature (≥39.0 °C) 4 0.77 (0.12) <0.001
Sex (male) 5 0.63 (0.11) <0.001
Duration fever (days) 6 0.51 (0.20) 0.009
Age (≥1 year) 7 −0.42 (0.12) 0.001
Saturation (<94 % O2) NA NA NA
Tachypnoea NA NA NA
SBIM : child is managed as having SBI according to participant
NA not applicable, items could not been tested with DCE analyses
Table 6 Clinical risk scores (video vignettes) versus prediction model
risk scores (Feverkidstool) in children managed as SBI (SBIM=yes)
VAS2 (%)a Feverkidstool (%)a
Video vignettes (no.) SBIM yes n=365 n=365
Risk ≤10 %
12 5.0 (2.0–9.5) 16.3
13 – –
Risk 10–50 %
16 15.0 (15.0–15.0) 2.0
8 20.0 (12.0–30.0) 8.9
3 23.0 (9.0–61.0) 7.2
20 29.0 (12.5–61.8) 3.8
9 30.5 (8.3–66.3) 11.6
14 47.0 (32.0–76.8) 36.9
Risk ≥50 %
21 54.0 (17.8–80.3) 12.7
19 59.0 (45.0–90.0) 7.3
2 60.0 (30.0–80.0) 38.2
7 60.0 (30.0–72.0) 2.3
1 62.0 (50.0–62.0) 20.6
6 68.0 (35.0–83.0) 19.0
15 68.0 (52.3–80.8) 50.5
10 70.0 (44.5–90.0) 7.7
11 70.0 (57.5–81.0) 4.8
4 71.0 (35.0–80.0) 9.7
5 72.0 (50.0–90.0) 22.2
18 80.0 (21.0–82.0) 6.6
17 83.0 (50.0–92.5) 28.1
Total 60.0 (30.0–80.5) 12.7 (7.7–28.1)
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appearance and aberrant circulatory signs in their febrile child
evaluation, which were not the most influencing factors ac-
cording to the Feverkidstool. For the Feverkidstool respiratory
predictors as chestwall retractions and oxygen saturation were
more powerful influencing factors. Furthermore, we found
that CRP levels influenced clinical risk scores differently in
children with or without initial SBI management, with higher
influence of clinical factors than of CRP value. In our study
population, this approach was not enhanced by experiences of
errors in the past. These insights in influencing factors in the
clinical prediction of febrile children at risk for SBI helps us to
understand, review and evaluate clinical management
decisions.
Compared to prediction model based risk scores, thresh-
olds of children who were not managed as having a SBI were
more comparable, ranging from 7 to 16 %. We might have to
conclude that this risk threshold is justified as SBI rule-out
threshold, but no agreement can be defined on rule-in thresh-
olds as there appears too much difference between prediction
model and the clinical stepwise risk assessment in children
managed as SBI.
Strengths and limitations
The main strength of this study is the use of real-life videos
instead of paper-case patients. This approach is a more repre-
sentative way of portraying real life, and there is an evolving
evidence base on the use of patient video cases as educational
interventions [8, 23].
A second strength of the study is the use of the
Feverkidstool as an arithmetic model to compare the subjec-
tive overall assessment of the clinician when evaluating the
febrile child. In a review describing vignette studies on med-
ical decision behaviour, it was concluded that most studies on
this topic did not compare their results to some sort of norma-
tive benchmark [3]. Moreover, the role of prediction models
becomes greater, as clinicians may increasingly rely on
alarming signs and symptoms described in (inter)national clin-
ical guidelines and prediction models due to decreasing inci-
dence of SBI. Although, there was a discrepancy in risk as-
sessment of some video vignettes (e.g. vignettes 7, 11 and 18),
probably due to the absence of variables as decreased con-
sciousness or agitation in the Feverkidstool.
There are some other limitations in this study. Videos still
lack some aspects of real life such as observation time or
concise descriptions of patients’ history. However, from liter-
ature, we know that more detailed case descriptions will be
assigned a higher subjective probability of disease than a brief
abstract of the same case, even if they contain the same disease
information [11]. Another limitation includes the determina-
tion of some clinical variables by the clinicians’ judgement (ill
appearance, chestwall retractions and capillary refill time). In
this way, misclassification of these clinical predictors could
have occurred. However, this approach does reflect clinical
practice and therefor may just strengthen generalisability of
our results.
Next, the DCE analysis had to be performed within the
availability of a limited number of video vignettes. As a con-
sequence, we were forced to exclude or merge some predictor
variables (e.g. oxygen saturation and tachypnoea) to meet the
DCE theory design. Second, although a response rate of 50 %
for clinicians was similar to other DCE studies, this response
rate is not optimal [2, 9, 29]. However, due to the experienced
background of all participants, we assume limited answer var-
iability resulting in representative study results.
Conclusion
In this study on real-life video vignettes, we observed high
risk scores in clinicians’ risk estimation of SBI management in
febrile children, and these risks are mostly influenced by the
clinical characteristics ill appearance and aberrant circulatory
signs. Uniform risk thresholds at which one should start SBI
management in febrile children remains unclear, as the
Table 7 Clinical risk scores (video vignettes) versus prediction model
risk scores (Feverkidstool) children not managed as SBI (SBIM=no)
VAS1 (%)aFeverkidstool
(%)aVideo vignettes (no.)
SBIM no n=517 n=517
Risk ≤10 %
16 1.0 (0.0–5.5) 2.0
13 4.0 (0.8–12.0) 5.7
12 6.0 (4.0–16.5) 16.3
9 8.5 (4.0–16.3) 11.6
3 10.0 (3.0–17.0) 7.2
8 10.0 (6.0–18.0) 8.9
20 10.0 (7.0–20.3) 3.8
Risk 10–50 %
10 13.0 (13.0–13.0) 7.7
21 15.5 (5.3–28.0) 12.7
7 17.0 (10.0–28.0) 2.3
1 20.0 (10.0–39.0) 20.6
14 20.0 (10.0–31.3) 36.9
17 20.0 (20.0–20.0) 28.1
19 25.0 (15.5–48.0) 7.3
11 30.0 (20.0–53.5) 4.8
5 40.0 (40.0–40.0) 22.2
6 40.0 (17.5–57.5) 19.0
2 42.0 (33.0–74.5) 38.2
4 46.0 (22.0–60.0) 9.7
15 46.5 (26.0–64.5) 50.5
Risk ≥50 %
18 60.0 (31.0–71.0) 6.6
Total 16.0 (5.0–32.0) 7.3 (5.7–16.3)
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concept of clinicians’ dichotomous risk thresholds was hardly
comparable to the overall SBI risk assessment of the predic-
tion model. However, more consistent results were found for
clinical and prediction model-based risk thresholds at which
we refrain from SBI management in the febrile child visiting
the emergency department.
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